Cognita LabsSimplifying pulmonary care
Cognita Labs
Rising global urbanization has led to a steady increase in respiratory illnesses. Pollution, smoking, second-hand inhalation and biomass-based cooking are contributing to both Chronic Obstructive Pulmonary Diseases (COPD) and Obstructive Airways Diseases (OAD) like Asthma. Together, respiratory illnesses affect an estimated 650 million globally, which is nearly 10% of world’s population. Despite their significant impact on quality of life, a significant number of OAD and COPD cases remain undiagnosed, under-diagnosed or inaccurately diagnosed.
Spirometry is the workhorse of pulmonary lung function testing, and can provide significant information about patient’s lung function. Spirometry is an established method to detect both obstructive and restrictive respiratory illnesses. However, spirometers have not seen much use outside the PFT lab due to the fact that commercial spirometers are designed to work in clinical environments, to be operated by well-trained technicians. As a result, spirometry remains generally limited to larger hospitals and dedicated Pulmonary Function Testing (PFT) labs.
Cognita Labs has developed PulmoScan, a next generation of smart portable airway assessment device, with an assistive coaching tablet application and a cloud support. PulmoScan’s innovative zero-effort quick test makes it possible to integrate respiratory testing with on the go workflows such as high volume clinics, pediatric offices where quality spirometry is often difficult.
PulmoScan is a Class II FDA cleared device and was developed from ground-up to allow minimally trained medical professionals to conduct accurate lung assessment. Click here for more information.
We have developed world’s first inhaler attachment for MDI, that can measure inhaler use with high granularity. Cognita’s CapMedic provides real-time audio-visual interactive guidance on correct use of inhalers and also measure correctness of inhaler use, time and frequency of its use. CapMedic is also a home spirometer, measures FEV1 and PEF.
CapMedic is a Class II FDA cleared device. Please visit the website for more information.
UltraSpiro is the world’s first intelligent coaching spirometer with the highest flow sensitivity in the market with <1% error-rates. The connected spirometer communicates with state of the art mobile app and cloud platform
Securely share data with your physician about medication use and lung health.
Providers can now make data-driven decisions with complete medication and lung function history, even remotely.
Reimbursable under the new CMS telehealth policy.
